Jazz hands Tobias CMO role
This article was originally published in Scrip
Executive Summary
Dr Jeffrey Tobias has joined Jazz Pharmaceuticals as chief medical officer and senior vice-president of R&D, effective October 17. Dr Tobias has 20 years' experience in the biopharma industry and most recently served as executive vice-president of R&D at NeurogesX, where he was also CMO from 2005. Jazz recently announced that it is taking over Azur Pharma (scripintelligence.com, 22 September 2011).